Classification of renal cell cancer based on (cyto)genetic analysis

Contributions to Nephrology

Volumn 128, Issue , 1999, Pages 51-61

  Van Den Berg, Eva ^a   Dijkhuizen, Trijnie ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; CLASSIFICATION; CYTOGENETICS; GENETICS; HUMAN; KIDNEY CARCINOMA; KIDNEY TUMOR; METHODOLOGY; REVIEW; SENSITIVITY AND SPECIFICITY;

ANIMALS; CARCINOMA, RENAL CELL; CYTOGENETICS; HUMANS; KIDNEY NEOPLASMS; SENSITIVITY AND SPECIFICITY;

EID: 0033257794     PISSN: 03025144     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000059979     Document Type: Article

References (107)

1. Weiss LM, Gelb AB, Medeiros LJ: Adult renal epithelial neoplasms. Am J Clin Pathol 1995;103:624-635.
2. Motzer RJ, Bander NH, Nanus DM: Renal cell carcinoma. N Engl J Med 1996;335:865-875.
3. Sandberg AA, Meloni-Ehrig AM: Renal cancer: Genetic and cytogenetic aspects; in Bertino JR (ed): Encyclopedia of Cancer. San Diego, Academic Press, 1997, vol III, pp 1522-1540.
4. de Jong B, Molenaar IM, Leeuw JA, Idunberg VJ, Oosterhuis JW: Cytogenetics of a renal adenocarcinoma in a 2-year-old child. Cancer Genet Cytogenet 1986;21:165-169.
5. Pedersen RK, Faurskov B, Hejl M, Kerndrup GB: Chromosome alterations in renal cell carcinoma of childhood may correspond to aberrations in adults. Cancer Genet Cytogenet 1998;106:166-169.
6. Bjornsson J, Short MP, Kwiatkowski DJ, Henske EP: Tuberous sclerosis-associated renal cell carcinoma - Clinical, pathological, and genetic features. Am J Pathol 1996;149:1201-1208.
7. Hughson MD, Schmidt L, Zbar B, Daugherty S, Meloni AM, Silva FG, Sandberg AA: Renal cell carcinoma of end-stage renal disease: A histopathologic and molecular genetic study. J Am Soc Nephrol 1996;7:2461-2468.
8. Kovacs G: High frequency of papillary renal-cell tumours in end-stage kidneys: Is there a molecular genetic explanation? Nephrol Dial Transplant 1995;10:593-596.
9. Mandel JS, McLaughlin JK, Schlehofer B, Mellemgaard A, Helmert U, Lindblad P, McCredie M, Adami HO: International renal-cell cancer study. 4. Occupation. Int J Cancer 1995;61:601-605.
10. Grawitz P: Die sogenannten Lipome der Niere. Virchows Arch [A] 1883;93:39-45.
11. Bannasch P, Zerban H: Animal models and renal carcinogenesis; in Eble JN (ed): Tumors and Tumor-Like Conditions of the Kidneys and Ureters. New York, Churchill Livingstone, 1990, pp 1 -34.
12. Murphy WM, Beckwith JB, Farrow GM: Tumors of the kidney, bladder, and related urinary structures. Washington, Armed Forces Institute of Pathology, 1994.
13. Fleming S: The impact of genetics on the classification of renal carcinoma. Histopathology 1993;22:89-92.
14. Storkel S, Eble JN, Adlakha K, Amin M, Blute ML, Bostwick DG, Darson M, Delahunt B, Iczkowski K: Classification of renal cell carcinoma: Workgroup No 1. Union Internationale Contre Le Cancer (UICC) and the American Joint Committee on Cancer (AJCC). Cancer 1997;80:987-989.
15. Thoenes W, Storkel S, Rumpelt HJ: Histopathology and classification of renal cell tumors (adenomas, oncocytomas and carcinomas). The basic cytological and histopathological elements and their use for diagnostics. Pathol Res Pract 1986;181:125-143.
16. Storkel S, van den Berg E: Morphological classification of renal cancer. World J Urol 1995;13:153-158.
17. Kovacs G, Akhtar M, Beckwith BJ, Bugert P, Cooper CS, Delahunt B, Eble JN, Fleming S, Ljungberg B, Medeiros LJ, Moch H, Reuter VE, Ritz E, Roos G, Schmidt D, Srigley JR, Storked S, van den Berg E, Zbar B: The Heidelberg classification of renal cell tumours. J Pathol 1997;183:131-133.
18. Brown JA, Anderl KL, Borell TJ, Qian J, Bostwick DG, Jenkins RB: Simultaneous chromosome 7 and 17 gain and sex chromosome loss provide evidence that renal metanephric adenoma is related to papillary renal cell carcinoma. J Urol 1997;158:370-374.
19. Jones EC, Pins M, Dickersin GR, Young RH: Metanephric adenoma of the kidney: A clinicopathological, immunohistochemical, flow cytometric, cytogenetic, and electron microscopic study of seven cases. Am J Surg Pathol 1995;19:615-626.
20. Lager DJ, Huston BJ, Timmerman TG, Bonsib SM: Papillary renal tumors: Morphologic, cytochemical and genotypic features. Cancer 1995;76:669-673.
21. Kovacs G: Molecular cytogenetics of renal cell tumors. Adv Cancer Res 1993;62:89-124.
22. Renshaw AA, Fletcher JA: Trisomy 3 in renal cell carcinoma. Mod Pathol 1997;10:481-484.
23. Balzarini P, Dal Cin P, Roskams T, Polito P, Van Poppel H, Van Damme B, Baert L, Van den Berghe H: Histology may depend on the presence of partial monosomy or partial trisomy 3 in renal cell carcinoma. Cancer Genet Cytogenet 1998;105:6-10.
24. Hughson MD, Dickman K, Bigler SA, Meloni AM, Sandberg AA: Clear-cell and papillary carcinoma of the kidney: An analysis of chromosome 3, 7, and 17 abnormalities by microsatellite amplification, cytogenetics, and fluorescence in situ hybridization. Cancer Genet Cytogenet 1998;106:93-104.
25. Palmedo G, Fischer J, Kovacs G: Fluorescent microsatellite analysis reveals duplication of specific chromosomal regions in papillary renal cell tumors. Lab Invest 1997;77:633-638.
26. Dijkhuizen T, van den Berg A, van den Berg E, Storkkel S, de Jong B, Seitz G, Henn W: Chromosomal findings and p53 mutation analysis in chromophilic renal cell carcinomas. Int J Cancer 1996;68:47-50.
27. Henn W, Zwergel T, Wullich B, Thonnes M, Zang KD, Seitz G: Bilateral multicentric papillary renal tumors with heteroclonal origin based on tissue-specific karyotype instability. Cancer 1993;72:1315-1318.
28. Kovacs G, Fuzesi L, Emannuel A, Kung H-F: Cytogenetics of papillary renal cell tumors. Gene Chromosome Cancer 1991;3:249-255.
29. van den Berg E, Dijkhuizen T, Oosterhuis JW, Geurts van Kessel A, de Jong B, Storkel S: Cytogenetic classification of renal cell cancer. Cancer Genet Cytogenet 1997;95:103-107.
30. Palmedo G, Fischer J, Kovacs G: Duplications of DNA sequences between loci D20S478 and D20S206 at 20q11.1 and between loci D20S902 and D20S480 at 20q13.2 mark new tumor genes in papillary renal cell carcinoma. Lab Invest 1999;79:311-316.
31. Schmidt L, Duh FM, Chen F, Kishida T, Glenn G, Choyke P, Scherer SW, Zhuang Z, Lubensky I, Dean M, Allikmets R, Chidambaram A, Bergerheim UR, Feltis JT, Casadevall C, Zamarron A, Bernues M, Richard S, Lips CJ, Walther MM, Tsui LC, Geil L, Orcutt ML, Stackhouse T, Zbar B, et al: Germline and somatic mutations in thé tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas. Nat Genet 1997;16:68-73.
32. Schmidt L, Junker K, Nakaigawa N, Kinjerski T, Weirich G, Miller M, Lubensky I, Neumann HP, Brauch H, Decker J, Vocke C, Brown JA, Jenkins R, Richard S, Bergerheim U, Gerrard B, Dean M, Linehan WM, Zbar B: Novel mutations of the MET proto-oncogene in papillary renal carcinomas. Oncogene 1999;18:2343-2350.
33. Glukhova L, Goguel AF, Chudoba I, Angevin E, Pavon C, Terrier-Lacombe MJ, Meddeb M, Escudier B, Bernheim A: Over rep resent at ion of 7q31 and 17q in renal cell carcinomas. Gene Chromosome Cancer 1998;22:171-178.
34. Dijkhuizen T, van den Berg E, Wilbrink M, Weterman M, Geurts van Kessel A, Storkel S, Folkers RP, Braam A, de Jong B: Distinct Xp11.2 breakpoints in two renal cell carcinomas exhibiting X; autosome translocations. Gene Chromosome Cancer 1995;14:43-50.
35. Tomlinson GE, Nisen PD, Timmons CF, Schneider NR: Cytogenetics of a renal cell carcinoma in a 17-month-old child: Evidence for Xp11.2 as a recurring breakpoint. Cancer Genet Cytogenet 1991;57:11-17.
36. Meloni AM, Sandberg AA, Pontes JE, Dobbs RM: Translocation (X; 1)(p11.2; q21): A subtype of renal adenocarcinomas. Cancer Genet Cytogenet 1992;63:100-101.
37. Meloni AM, Dobbs RM, Pontes JE, Sandberg AA: Translocation (X-1) in papillary renal cell carcinoma: A new cytogenetic subtype. Cancer Genet Cytogenet 1993;65:1-6.
38. Shipley JM, Birdsall S, Clark J, Crew J, Gill S, Linehan M, Gnarra J, Fisher S, Craig IW, Cooper CS: Mapping the X chromosome breakpoint in two papillary renal cell carcinoma cell lines with a t(X; 1)(p11.2; q21.2) and the first report of a female case. Cytogenet Cell Genet 1995;71:280-284.
39. Kardas I, Denis A, Babinska M, Gronwald J, Podolski J, Zajaczek S, Kram A, Lubinski J, Limon J: Translocation (X; 1)(p11.2; q21) in a papillary renal cell carcinoma in a 14-year-old girl. Cancer Genet Cytogenet 1998;101:159-161.
40. Dal Cin P, Stas M, Sciot R, De Wever I, Van Damme B, Van Den Berghe H: Translocation (X; 1) reveals metastasis 31 years after renal cell carcinoma. Cancer Genet Cytogenet 1998;101:58-61.
41. Yenamandra A, Zhou XT, Trinchitella L, Susin M, Sastry S, Mehta L: Renal cell carcinoma with X; 1 translocation in a child with Klinefelter syndrome. Am J Med Genet 1998;77:281-284.
42. Perot C, Bougaran J, Boccon Gibod L, Storkel S, Leverger G, van den Akker J, Taillemite JL, Couturier J: Two new cases of papillary renal cell carcinoma with t(X; 1)(p11; q21) in females. Cancer Genet Cytogenet 1999;59:2021-2050.
43. Weterman MAJ, Wilbrink M, Janssen I, Janssen HAP, van den Berg E, Fisher SE, Craig I, Geurts van Kessel A: Molecular cloning of the papillary renal cell carcinoma-associated translocation (X; 1)(p11; q21) breakpoint. Cytogenet Cell Genet 1996;75:2-6.
44. Weterman M, Wilbrink M, Dijkhuizen T, van den Berg E, Geurts van Kessel A: Fine mapping of the Iq21 breakpoint of the papillary renal cell carcinoma-associated (X; 1) translocation. Hum Genet 1996;98:16-21.
45. Weterman MAJ, Wilbrink M, Geurts van Kessel A: Fusion of the transcription factor TFE3 gene to a novel gene: PPCC, in the t(X; 1)(p11; q21)-positive papillary renal cell carcinomas. Proc Natl Acad Sci USA 1996;93:15294-15298.
46. Sidhar SK, Clark J, Gill S, Hamoudi R, Crew AJ, Gwilliam R, Ross M, Linehan WM, Birdsall S, Shipley J, Cooper CS: The t(X; 1)(p11.2; q21.2) translocation in papillary renal cell carcinoma fuses a novel gene PRCC to the TFE3 transcription factor gene. Hum Mol Genet 1996;5:1333-1338.
47. Kovacs G, Wilkens L, Papp T: Nondisjunction reduplication of chromosome 3 is not a common mechanism in the development of human renal cell tumors. Cytogenet Cell Genet 1988;48:242-243.
48. van der Hout AH, van den Berg E, Van der Vlies P, Dijkhuizen T, Storkel S, Oosterhuis JW, de Jong B, Buys CHCM: Loss of heterozygosity at the short arm of chromosome-3 in renal-cell cancer correlates with the cytological tumour type. Int J Cancer 1993;53:353-357.
49. van den Berg E, van der Hout AH, Oosterhuis JW, Storked S, Dijkhuizen T, Dam A, Zweers HMM, Mensink HJA, Buys CHCM, de Jong B: Cytogenetic analysis of epithelial renal-cell tumors: Relationship with a new histopathological classification. Int J Cancer 1993;55:223-227.
50. Gnarra JR, Duan DR, Weng YK, Humphrey JS, Chen DYT, Lee S, Pause A, Dudley CF, Latif F, Kuzmin I, Schmidt L, Duh FM, Stackhouse T, Chen F, Kishida T, Wei MH, Lerman MI, Zbar B, Klausner RD, Linehan WM: Molecular cloning of the von Hippel-Lindau tumor suppressor gene and its role in renal carcinoma. Biochim Biophys Acta 1996;1242:201-210.
51. Whaley JM, Naglich J, Gelbert L, Hsia YE, Lamiell JM, Green JS, Collins D, Neumann HPH, Laidlaw J, Li FP, Klein-Szanto AJP, Seizinger BR, Kley N: Germ-line mutations in the von HippelLindau tumor-suppressor gene are similar to somatic von Hippel-Lindau aberrations in sporadic renal cell carcinoma. Am J Hum Genet 1994;55:1092-1102.
52. Gnarra JR, Lerman MI, Zbar N, Linehan WM: Genetics of renal-cell carcinoma and evidence for a critical role for von Hippel-Lindau in renal tumorigenesis. Semin Oncol 1995;22:3-8.
53. Moch H, Schraml P, Bubendorf L, Richter J, Gasser TC, Mihatsch MJ, Sauter G: Intratumoral heterogeneity of von Hippel-Lindau gene deletions in renal cell carcinoma detected by fluorescence in situ hybridization. Cancer Res 1998;58:2304-2309.
54. Clifford SC, Prowse AH, Affara NA, Buys CHCM, Maher ER: Inactivation of the von Hippel-Lindau (VHL) tumour suppressor gene and allelic losses at chromosome arm 3p in primary renal cell carcinoma: Evidence for a VHL-independent pathway in clear cell renal tumourigenesis. Gene Chromosome Cancer 1998;22:200-209.
55. van den Berg A, Dijkhuizen T, Draaijers TG, Hulsbeek MMF, Maher ER, van den Berg E, Storkel S, Buys CHCM: Analysis of multiple renal cell adenomas and carcinomas suggests allelic loss at 3p21 to be a prerequiste for malignant development. Gene Chromosome Cancer 1997;19:228-232.
56. van den Berg A, Buys CHCM: Involvement of multiple loci on chromosome 3 in renal cell cancer development. Gene Chromosome Cancer 1997;19:59-76.
57. Huebner K, Garrison PN, Barnes LD, Croce CM: The role of the FHIT/FRA3B locus in cancer. Annu Rev Genet 1998;32:7-31.
58. Bugert P, Wilhelm M, Kovacs G: FHIT gene and the FRA3B region are not involved in the genetics of renal cell carcinomas. Gene Chromosome Cancer 1997;20:9-15.
59. Luan XD, Shi GP, Zohouri M, Paradee W, Smith DI, Decker HJ, Cannizzaro LA: The FHIT gene is alternatively spliced in normal kidney and renal cell carcinoma. Oncogene 1997;15:79-86.
60. Lott ST, Lovell M, Naylor SL, Killary AM: Physical and functional mapping of a tumor suppressor locus for renal cell carcinoma within chromosome 3p12. Cancer Res 1998;58:3533-3537.
61. Zbar B, Lerman M: Inherited carcinomas of the kidney. Adv Cancer Res 1998;75:163-201.
62. Koolen MI, van der Meyden PM, Bodmer D, Eleveld M, van der Looij E, Brunner H, Smits A, van den Berg E, Smeets D, Geurts van Kessel A: A familial case of renal cell carcinoma and a t(2; 3) chromosome translocation. Kidney Int 1998;53:273-275.
63. Bodmer D, Eleveld MF, Ligtenberg MJL, Weterman MAJ, Janssen BAP, Smeets DFCM, de Wit PEJ, van den Berg A, van den Berg E, Koolen MI, Geurts van Kessel A: An alternative route for multistep tumorigenesis in a novel case of hereditary renal cell cancer and a t(2; 3)(q35; q21) chromosome translocation. Am J Hum Genet 1998;62:1475-1483.
64. Bugert P, Von Knobloch R, Kovacs G: Duplication of two distinct regions on chromosome 5q in non-papillary renal-cell carcinomas. Int J Cancer 1998;76:337-340.
65. de Jong B, Oosterhuis JW, Idenburg VJ, Castedo SM, Dam A, Mensink HJ: Cytogenetics of 12 cases of renal adenocarcinoma. Cancer Genet Cytogenet 1988;30:53-61.
66. Presti JC, Rao PH, ChenQ, Reuter VE, Li FP, Fair WR, Jhanwar SC: Histopathological, cytogenetic, and molecular characterization of renal cortical tumors. Cancer Res 1991;51:1544-1552.
67. Meloni AM, Bridge J, Sandberg AA: Reviews on chromosome studies in urological tumors. 1. Renal tumors. J Urol 1992;148:253-265.
68. Maloney KE, Norman RW, Lee CLY, Millard OH, Welch JP: Cytogenetic abnormalities associated with renal cell carcinoma. J Urol 1991;146:692-696.
69. Schullerus D, Herbers J, Chudek J, Kanamaru H, Kovacs G: Loss of heterozygosity at chromosomes 8p, 9p, and 14q is associated with stage and grade of non-papillary renal cell carcinomas. J Pathol 1997;183:151-155.
70. Herbers J, Schullerus D, Muller H, Kenck C, Chudek J, Weimer J, Bugert P, Kovacs G: Significance of chromosome arm 14q loss in nonpapillary renal cell carcinomas. Gene Chromosome Cancer 1997;19:29-35.
71. Horton TM, Petros JA, Heddi A, Shoffner J, Kaufman AE, Graham SD, Gramlich T, Wallace DC: Novel mitochondrial DNA deletion found in a renal cell carcinoma. Gene Chromosome Cancer 1996;15:95-101.
72. Meloni AM, Sandberg AA, White RD: -Y, -1 as recurrent anomaly in oncocytoma. Cancer Genet Cytogenet 1992;61:108-109.
73. Crotty TB, Lawrence KM, Moertel CA, Bartelt DH, Batts KP, Dewald GW, Farrow GM, Jenkins RB: Cytogenetic analysis of 6 renal oncocytomas and a chromophobe cell renal carcinoma: Evidence that -Y, -1 may be a characteristic anomaly in renal oncocytomas. Cancer Genet Cytogenet 1992;61:61-66.
74. Presti JC, Moch H, Reuter VE, Huynh D, Waldman FM: Comparative genomic hybridization for genetic analysis of renal oncocytomas. Gene Chromosome Cancer 1996;17:199-204.
75. van den Berg E, Dijkhuizen T, Storkel S, Brutel de la Riviere G, Dam A, Mensink HJ, Oosterhuis JW, de Jong B: Chromosomal changes in renal oncocytomas. Evidence that t(5; 11)(q35; q13) may characterize a second subgroup of oncocytomas. Cancer Genet Cytogenet 1995;79:164-168.
76. Dijkhuizen T, van den Berg E, Storkel S, de Vries B, van der Veen AY, Wilbrink M, Geurtz van Kessel A, de Jong B: Renal oncocytoma with t(5; 12; 11), der(1)t(1; 8) and add(19): 'True' oncocytoma or chromophobe adenoma? Int J Cancer 1997;73:521-524.
77. Neuhaus C, Dijkhuizen T, van den Berg E, Storkel S, Stockle M, Mensch B, Huber C, Decker HJ: Involvement of the chromosomal region Ilql3 in renal oncocytoma: Case report and literature review. Cancer Genet Cytogenet 1997;94:95-98.
78. Sinke RJ, Dijkhuizen T, Janssen B, Olde Weghuis D, Merkx G, van den Berg E, Schuuring E, Meloni AM, de Jong B, Geurts van Kessel A: Fine mapping of the human renal oncocytoma-associated translocation (5; 11)(q35; q13) breakpoint. Cancer Genet Cytogenet 1997;96:95-101.
79. Trash-Bingham CA, Salazar H, Greenberg RE, Tartof KD: Loss of heterozygosity studies indicate that chromosome arm 1p harbors a tumor suppressor gene for renal oncocytomas. Gene Chromosome Cancer 1996;16:64-67.
80. Herbers J, Schullerus D, Chudek J, Bugert P, Kanamaru H, Zeisler J, Ljungberg B, Akhtar M, Kovacs G: Lack of genetic changes at specific genomic sites separates renal oncocytomas from renal cell carcinomas. J Pathol 1998;184:58-62.
81. Kovacs A, Kovacs G: Low chromosome number in chromophobe renal cell carcinomas. Gene Chromosome Cancer 1992;4:267-268.
82. Speicher MR, Schoell B, du Manoir S, Schrock E, Ried T, Cremer T, Storkel S, Kovacs A, Kovacs G: Specific loss of chromosomes 1, 2, 6. 10, 13, 17, and 21 in chromophobe renal cell carcinomas revealed by comparative genomic hybridization. Am J Pathol 1994;145:356-364.
83. Shuin T, Kondo K, Sakai N, Kaneko S, Yao M, Nagashima Y, Kitamura H, Yoshida MA: A case of chromophobe renal cell carcinoma associated with low chromosome number and microsatellite instability. Cancer Genet Cytogenet 1996;86:69-71.
84. Gerharz CD, Moll R, Storkel S, Ramp U, Hildebrandt B, Molsberger G, Koldovsky P, Gabbert HE: Establishment and characterization of two divergent cell lines derived from a human chomophobe renal cell carcinoma. Am J Pathol 1995;146:953-962.
85. Marras S, Faa G, Scarpa R, Valdes E, Vanni R: Diagnosis of chromophobe renal cell carcinoma by chromosomal analysis. Tumori 1997;83:753-755.
86. Bugert P, Gaul C, Weber K, Herbers J, Akhtar M, Ljungberg B, Kovacs G: Specific genetic changes of diagnostic importance in chromophobe renal cell carcinomas. Lab Invest 1997;76:203-208.
87. Gunawan B, Bergmann F, Braun S, Hemmerlein B, Ringert RH, Jakse G, Fuzesi L: Polyploidization and losses of chromosomes I, 2,6, 19, 13, and 17 in three cases of chromophobe renal cell carcinomas. Cancer Genet Cytogenet 1999;110:57-61.
88. Baizarini P, Grigolato P, Tardanico R, Cadei M, Cunico SC, Cozzoli A, Zanotelli T, Van Den Berghe H, Dal Cin P: Multitechnical pathological diagnosis in chromophobe renal cell carcinoma. Oncol Rep 1999;6:295-299.
89. Dijkhuizen T, van den Berg , Storkel S, de Jong B: Chromosome changes in a metastasis of a chromophobe renal cell tumor. Cancer Genet Cytogenet 1998;105:86-89.
90. Fuzesi L, Cober M, Mittermayer C: Collecting duct carcinoma: Cytogenetic characterization. Histopathology 1992;21:155-160.
91. Gregori-Romero MA, Morell-Quadreny L, Llombart-Bosch A: Cytogenetic analysis of three primary Bellini duct carcinomas. Gene Chromosome Cancer 1996;15:170-172.
92. Schoenberg M, Cairns P, Brooks JD, Marshall FF, Epstein JI, Isaacs WB, Sidransky D: Frequent loss of chromosome arms 8p and 13q in collecting duct carcinoma (CDC) of the kidney. Gene Chromosome Cancer 1995;12:76-80.
93. Steiner G, Cairns P, Polascik TJ, Marshall FF, Epstein JI, Sidransky D, Schoenberg MK: Highdensity mapping of chromosomal arm Iq in renal collecting duct carcinoma: Region of minimal deletion at 1q32.1-32.2. Cancer Res 1996;56:5044-5046.
94. Kovacs G: The value of molecular genetic analysis in the diagnosis of renal cell tumours. World J Urol 1994;12:64-68.
95. Thrash-Bingham CA, Greenberg RE, Howard S, Bruzel A, Bremer M, Goll A, Salazar H, Freed JJ, Tartof KD: Comprehensive allelotyping of human renal cell carcinomas using microsatellite DNA probes. Proc Natl Acad Sci USA 1995;92:2854-2858.
96. Grammatico P, Cianciulli AM, Grammatico B, Di Rosa C, Del Porto G: The first Cytogenetic study of a sarcomatoid renal cell carcinoma. J Exp Clin Cancer Res 1993;12:19-21.
97. Dijkhuizen T, van den Berg E, van den Berg A, van de Veen A, Dam A, Faber H, Buys CHCM, Storkel S, de Jong B: Genetics as a diagnostic tool in sarcomatoid renal-cell cancer. Int J Cancer 1997;72:265-269.
98. Jiang F, Moch H, Riichter J, Egenter C, Gasser T, Bubendorf L, Gschwind R, Sauter G, Mihatsch MJ: Comparative genomic hybridization reveals frequent chromosome 13q and 4q losses in renal carcinomas with sarcomatoid transformation. J Pathol 1998;185:382-388.
99. Oda H, Nakatsuru Y, Ishikawa T: Mutations of the p53 gene and p53 protein overexpression are associated with sarcomatoid transformation in renal cell carcinomas. Cancer Res 1995;55:658-662.
100. Emanuel A, Szucs S, Weier HUG, Kovacs G: Clonal aberrations of chromosomes-X, Y, 7 and 10 in normal kidney tissue of patients with renal cell tumors. Gene Chromosome Cancer 1992;4:75-77.
101. Casalone R, Casalone PG, Minelli E, Portentoso P, Righi R, Meroni E, Giudici A, Donati D, Riva C, Salvatore S, Bono AV: Significance of the clonal and sporadic chromosome abnormalities in non-neoplastic renal tissue. Hum Genet 1992;90:71-78.
102. van den Berg E, Dijkhuizen T, Storkel S, Molenaar WM, de Jong B: Chromosomal abnormalities in non-neoplastic renal tissue. Cancer Genet Cytogenet 1995;85:152-154.
103. Knuutila S, Larramendy ML, Elfving P, El-Rifai W, Miettinen A, Mitelman F: Trisomy 7 in non-neoplastic tubular epithelial cells of the kidney. Hum Genet 1995;95:149-156.
104. Elfving P, Cigudosa JC, Lundgren R, Limon J, Mandahl N, Kristoffersson U, Heim S, Mitelman F: Trisomy 7, trisomy 10, and loss of the Y chromosome in short-term cultures of normal kidney tissue. Cytogenet Cell Genet 1990;53:123-125.
105. Elfving P, Aman P, Mandahl N, Lundgren R, Mitelman F: Trisomy 7 in nonneoplastic epithelial kidney cells. Cytogenet Cell Genet 1995;69:90-96.
106. Bugert P, Gaul C, Weber K, Herbers J, Akhtar M, Ljungberg B, Kovacs G: Specific genetic changes of diagnostic importance in chromophobe renal cell carcinomas. Lab Invest 1997;76:203-208.
107. Moch H, Presti JC, Sauter G, Buchholz N, Jordan P, Mihatsch MJ, Waldman FM: Genetic aberrations deteced by comparative genomic hybridization are associated with clinical outcome in renal cell carcinoma. Cancer Res 1996;56:27-30.